Is Push to Vaccinate Young Kids a Ploy by Pharma to Get COVID Shot on Pediatric Immunization Schedule?

If Pfizer’s COVID-19 vaccine is added to the pediatric vaccine schedule, and if it’s mandated like other childhood vaccines, it will become an evergreen market representing billions of dollars to the drug companies.

• Pfizer announced preliminary data from Phase 2/3 trials in children 6 months to under 5 years would be submitted to the U.S. Food and Drug Administration (FDA) for emergency use authorization; the data are based on 1,678 children and 10 who got sick, which Pfizer claims is an 80.3% effectiveness rate.
• Even vaccine advocate Dr. Paul Offit is dismayed at the number from which Pfizer is drawing conclusions. Just days before, New York announced the vaccine efficacy in children 5 to 11 years fell to 12% within two months after vaccination.
• Despite 48,833 records in the Vaccine Adverse Event Reporting System (VAERS) of adverse events in children under 18 from the vaccine, Pfizer says the shot for 6 months to under 5 years old has “a safety profile similar to placebo.”
• Moderna announced their submission to the FDA for children younger than 5 years has a 37% to 51% effectiveness, which is close to the effectiveness of the flu vaccine.
• Data from the Centers for Disease Control and Prevention (CDC) show that as the months roll by, more Americans are not taking or completing the shots to meet CDC criteria to be fully vaccinated. The push to vaccinate children may likely be related to the pharmaceutical industry’s goal to mandate the vaccine under full legal immunity from damages.

On May 23, Pfizer-BioNTech announced preliminary results from their Phase 2/3 trial evaluating a three-dose vaccine schedule for children 6 months to under 5 years of age would be submitted to the FDA for emergency use authorization (EUA).

Many in mainstream media are hailing this development as important to children’s health, writing, “many parents of these very young children have been really anxious to get their kids vaccinated” and “Parents hoping to get their youngest children vaccinated against COVID-19 got some encouraging news Monday.”

Yet, despite the continued push by mainstream media to encourage parents to vaccinate the very young, the Vaccine Monitor Survey from the Kaiser Family Foundation (KFF) found only 18% of parents with children under age 5 are planning to get their child vaccinated immediately.

Parents expressing concern for children’s safety

KFF reports that a larger number — 38% — are planning to wait to see the side effects the vaccine may have in younger children before making a decision and 27% have indicated they will definitely not have their child injected.

Importantly, the survey also found that “Just over half of parents of children in this age range say they do not have enough information about the vaccines’ safety and effectiveness for children under age 5.”

While information about vaccine injuries from the COVID-19 jab has been difficult to find on mainstream media, it is apparent from these numbers that many parents are concerned about their children’s safety and want more information before they’re willing to risk their health.

A paper published December 15, 2021, in the Journal of the American Medical Association (JAMA) referenced the previous survey by KFF, which found 27% of parents of children 5 to 11 years old were interested in giving their children the jab, which is a 9% drop from the survey in 2022.

The paper sought to smooth the waters with parents who were hesitant to vaccinate their children by attributing fear to misinformation and a misunderstanding of what “EUA” means.

It is interesting to note that the author of the paper has received research grants from Pfizer and Moderna, and also serves on the advisory boards for...

Read More HERE